Drug-induced elevation of vasopressin-like immunoreactivity in Raphe and septal regions of the mouse CNS.
Increases and decreases in the concentration or activity of vasopressin (VP) in mice result in facilitations and deficits in avoidance performance, respectively. An experiment was conducted to test the hypothesis that elevations in the central nervous system concentration of VP result from doses of d-amphetamine, strychnine sulfate and physostigmine known to induce facilitations of avoidance performance. An immunohistofluorescent technique was used to determine whether performance-facilitating doses of the three drugs elevated VP levels in a number of brain structures. A performance-facilitating dose of each of the three drugs was found to increase VP-like immunoreactivity in the dorsal raphe and lateral septum, but not in the substantia nigra, dentate gyrus or central amygdaloid nucleus.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003913:Dextroamphetamine / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010830:Physostigmine / Q000494:pharmacology; D012462:Saline Solution, Hypertonic; D013331:Strychnine / Q000494:pharmacology; D014667:Vasopressins / Q000032:analysis / Q000378:metabolism*
D012462:Saline Solution, Hypertonic; D014667:Vasopressins; D010830:Physostigmine; D013331:Strychnine; D003913:Dextroamphetamine